tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Kelcher, 7 are a HOLD (20%), 28 are a BUY (80%).
Analyst Jonathan Kelcher, currently employed at JEFFERIES, carries an average stock price target met ratio of 67.5% that have a potential upside of 27.09% achieved within 381 days. Previously, Jonathan Kelcher worked at BERNSTEIN, RBC, TD COWEN.
Jonathan Kelcher’s has documented 66 price targets and ratings displayed on 7 stocks. The coverage is on the Consumer Defensive sector.
Most recent stock forecast was given on EQIX, Equinix at 26-Jun-2025.
Analyst best performing recommendations are on EXETF (EXTENDICARE).
The best stock recommendation documented was for CONE (CYRUSONE) at 2/25/2016. The price target of $45 was fulfilled within 125 days with a profit of $12.44 (38.21%) receiving and performance score of 3.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 17-Mar-2020
$90.5
$0.14 (0.15%)
$87
4 years 7 months 9 days ago
(22-Mar-2022)
5/6 (83.33%)
$0.74 (0.82%)
133
Hold Since 17-Feb-2022
$90.5
$0.14 (0.15%)
$90
4 years 8 months 14 days ago
(17-Feb-2022)
16/17 (94.12%)
$1.14 (1.28%)
298
Hold Since 02-Feb-2022
$90.5
$0.14 (0.15%)
$66
4 years 8 months 29 days ago
(02-Feb-2022)
3/4 (75%)
$1.01 (1.13%)
371
$90.5
$0.14 (0.15%)
$90
4 years 8 months 30 days ago
(02-Feb-2022)
10/12 (83.33%)
$1.01 (1.13%)
177
Buy Since 01-Dec-2021
$90.5
4 years 11 months ago
(01-Dec-2021)
1/2 (50%)
$2.5 (2.84%)
148
What Year was the first public recommendation made by Jonathan Kelcher?
